CTRI/2024/06/068511尚未招募4 期
An Open-label Clinical Study to evaluate the safety and gastrointestinal tolerance (Product Compliance) of Maxvida High Protein in adults requiring isocaloric formula for enteral tube feeding. - NI
Signtura Health and nutrition0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Ready to Sign informed consent form or informed consent form signed by legally acceptable representatives.
- •2.Aged more than 18 years
- •3.Gender: Male & Female.
- •4.Hospitalized patients requiring isocaloric formula for enteral feeding.
- •5.Can tolerate enteral tube feeding.
- •6.Estimated duration of Hospital stays equal to or greater than 2 days.
排除标准
- •1.Receiving tube feeding prior to hospitalization.
- •2.Patients less than 18 years of age.
- •3.Patients having allergy to constituents of Maxvida High Protein.
- •4.Any evidence of organ dysfunction or any clinically significant deviation from the normal, in physical or clinical determinations.
研究者
相似试验
进行中（未招募）
1 期
An open-label clinical study to evaluate the safety and antiepileptic activity of ganaxolaone in treatment of patients diagnosed with infantile spansms.EUCTR2006-004286-33-PLMarinus Pharmceuticals, Inc.54
进行中（未招募）
不适用
An open-label clinical study to evaluate the safety and antiepileptic activity of ganaxolaone in treatment of patients diagnosed with infantile spasms.EUCTR2006-004286-33-CZMarinus Pharmceuticals, Inc.54
已完成
不适用
Clinical Study For Patients Requiring Tube FeedingCTRI/2019/12/022446Modi Mundi Pharma Private Limited15
已完成
不适用
Clinical Study For Hospitalized Patients Requiring isocaloric formulafor enteral tube feedingCTRI/2020/09/027831Modi Mundi Pharma Private Limited15
已完成
不适用
CelWel in Long CovidCTRI/2022/12/048144Carmel Research Consultancy Private Limited15